Skip to main content
Log in

Atomoxetine cost-effective in ADHD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Prasad S, Arellano J, Steer C, Libretto SE.Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK. International Journal of Clinical Practice 63: 1031-1040, No. 7, Jul 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atomoxetine cost-effective in ADHD. Pharmacoecon. Outcomes News 584, 4 (2009). https://doi.org/10.2165/00151234-200905840-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905840-00011

Keywords

Navigation